You are here

Closed

Reset

NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should visit the respective agency SBIR sites to read the official version of the solicitations and download the appropriate forms and rules.

Displaying 17151 - 17160 of 18911 results
  1. 20.5: NINDS Cooperative Program in Translational Research

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    Although translational research is supported through the general SBIR/STTR program announcement, the NINDS also has a Cooperative Program in Translational research (PAR-11-296). The NINDS Cooperative Program encourages Phase II and Fast-Track applications that directly address the identification and pre-clinical testing of new therapeutics for neurological disorders. The program will facilitate so ...

    STTRPhase IDepartment of Health and Human Services
  2. 20.6: Countermeasures Against Chemical Threats

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    NINDS manages the NIH Countermeasures Against Chemical Threats (CounterACT) program. CounterACT supports research and development on new and improved therapeutics or diagnostic technologies to prevent or mitigate the toxic effects from exposure to chemical threats, defined as toxic chemical agents that could be used in a terrorist attack against civilians, or those that could be released at toxic ...

    STTRPhase IDepartment of Health and Human Services
  3. 21: NATIONAL INSTITUTE OF NURSING RESEARCH (NINR)

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    The National Institute of Nursing Research (NINR) supports research focused on biological and behavioral aspects of critical health problems that confront the Nation. Emphasis is on seeking ways to reduce the burden of illness and disability by understanding and easing the effects of acute and chronic illness, improving health-related quality of life by preventing or delaying the onset of disease ...

    STTRPhase IDepartment of Health and Human Services
  4. 21.1: Research and Development of Technologies for Health Promotion and Alleviation, Adaptation to, or Management of Symptoms

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    A. Technologies to be used in the hospital, long-term care, hospice, assisted living facility, or home setting that improve symptom evaluation in persons with chronic conditions. Conditions of interest include congestive heart failure, cystic fibrosis, organ failure, cognitive impairment, renal disease, asthma, diabetes, or mobility impairments. B. Devices that improve the acceptance and ...

    STTRPhase IDepartment of Health and Human Services
  5. 21.2: Research and Development of Technologies to Enhance Self Care and Clinical Care

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    A. Technologies to assist patients to adhere to chronic regimens such as reminding children to take steroid inhalers during the day for asthma; alerting obese adults when high calorie and fat content foods are about to be eaten; adhering to medication regimens; and prompting sedentary adults to exercise. B. Devices that improve delivery of care to persons who have restricted or impaired ...

    STTRPhase IDepartment of Health and Human Services
  6. 21.3: Other Research Topic(s) Within the Mission of the Institute

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    A. Micro- and Nano-Systems, Platform Technologies. Development of BioMEMS, microfluidics and nanoscale technologies, including micro-total analysis systems, arrays, and biochips, for detection and quantitation of clinically relevant analytes in complex matrices. Application areas include biomedical research, clinical laboratory diagnostics, biodefense, high-throughput screening, drug delivery, ...

    STTRPhase IDepartment of Health and Human Services
  7. 22: NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES (NCATS)

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    NCATS provides laboratory scientists and clinical researchers with the environments and tools they need to understand, detect, treat, and prevent a wide range of diseases. This support enables discoveries that begin at a molecular and cellular level to move to animal-based studies, and then are translated to patient-oriented clinical research, resulting in cures and treatments for both common and ...

    STTRPhase IDepartment of Health and Human Services
  8. 22.1: Phase IIB Competing Renewal Awards

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    NCATS will accept Phase IIB SBIR Competing Renewal grant applications to continue research and development of complex instrumentation and tools for basic, translational or clinical research where extraordinary time and effort is needed for their research and development. The Phase IIB Competing Renewal award is intended to allow small businesses the opportunity to reach to a stage where interest a ...

    STTRPhase IDepartment of Health and Human Services
  9. 22.2: Pre-Clinical Innovation Technology Applications

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    A. Novel approaches for facilitating the discovery of therapeutics for rare and neglected tropical diseases: 1. Novel informatics approaches for repurposing known drugs for use as a therapeutic for a rare or neglected tropical disease; 2. Innovative phenotypic assay technologies useful for performing repurposing screens of known drug collections to identify potential th ...

    STTRPhase IDepartment of Health and Human Services
  10. 22.3: Clinical Innovation Technology Applications

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    A. Innovations to accelerate the utilization of personalized medicine: 1. Biomedical materials and medical devices; 2. Medical drug, biologics, device and product development; 3. Therapeutics; 4. Drug/product delivery systems; 5. Drug-device combination products; 6. Integrated bio-engineering and pharmacogenomi ...

    STTRPhase IDepartment of Health and Human Services
US Flag An Official Website of the United States Government